Analgesic medicine sales in Spain have shown a steady increase from 2013 to 2023. In 2023, the market stood at 878.3 million euros. Over the last two years, the market saw a year-on-year variation of 3.08% in 2022, followed by 2.49% in 2023. The compound annual growth rate (CAGR) over the past five years (2019-2023) has been 3.22%. Forecasts indicate that from 2024 to 2028, the CAGR will slow to 0.93%, with an expected growth rate of 4.76% over this period.
Future trends to watch for:
- Potential market saturation as the growth rate is expected to slow down.
- Impact of new product innovations and alternative pain management solutions.
- Regulatory changes and their effects on the market.
- Shifts in consumer behavior influenced by economic and societal factors.
